Table 3.
Multivariate analysis of prognostic factors associated with OS and PFS in patients
| Characteristic | Group | Overall survival | Progression-free survival | ||
|---|---|---|---|---|---|
| HR (95% CI) | P | HR (95% CI) | P | ||
| FIGO stage | I–II vs III–IVa | 0.537 (0.116–2.477) | 0.425 | 0.792 (0.258–2.429) | 0.683 |
| Pathology | Squamous | 1 | 0.000* | 1 | 0.152 |
| Adenocarcinoma | 1.920 (0.341–10.830) | 0.460 | 13.310 (0.430–3.993) | 0.635 | |
| Other patterns | 167.331 (14.868–1883.256) | 0.000* | 6.701 (0.964–46.592) | 0.055 | |
| Metastasis | Yes vs no | 20.972 (2.929–150.173) | 0.001* | 50.900 (14.145–232.464) | 0.000* |
| Recurrence | Yes vs no | / | / | 38.401 (8.692–169.649) | 0.000* |
Note: *Statistically significant.
Abbreviations: n, number; HR, hazard ratio; CI, confidence interval.